Theralink Technologies: Faith Zaslavsky, Mick Ruxin

Theralink Technologies has appointed Faith Zaslavsky as CEO. She will take the helm from Mick Ruxin, who will transition to the role of chief medical officer. Zaslavsky has served as the company's president and chief operating officer since December 2022. Prior to that, she spent more than 20 years at Myriad Genetics, most recently as president of oncology, where she was instrumental in the commercialization of tests to detect mutations in the BRCA1 and BRCA2 genes.